课题基金 / 基金详情

2020 Antibody Biology & Engineering Gordon Research Conference and Gordon Research Seminar

2020 Antibody Biology & Engineering Gordon Research Conference and Gordon Research Seminar
2020年抗体生物学
批准号:
9913160
负责人:
Jeanette Leusen
金额:
$0.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-02-05 至 2023-01-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目描述 该申请寻求对2020年戈登抗体生物学研究会议(GRC)的部分支持 和工程,连同配套的戈登研究研讨会(GRS)将于3月15日举行- 2020年20日在美国加利福尼亚州文图拉海滩万豪酒店举行。这是关于这个主题的第六次GRC和第四次GRS, 一个非常令人兴奋和有影响力的会议在社区的代表。这次会议的目的是 提供抗体生物学快速发展领域的重要最新发展的深入报道 和工程,在一个非正式的设置,旨在最大限度地讨论和互动。该领域具有广阔的 对各种生物学和临床重要主题的影响,这些主题广泛涉及多个领域, 在生物医学领域,包括免疫,传染病,炎症和肿瘤学。 此外,在这个会议系列的第四次,我们将纳入戈登研究研讨会(GRS)。 这已被证明是一个非常成功的除了戈登研究会议(GRC)。GRS将 在GRC之前运行。它将专门为研究生提供研讨会和海报会议, 博士后研究员和早期职业科学家,让他们介绍和讨论他们的研究。作为 在此之前,一位GRS主题演讲者和GRC主席将通过一个 指导课程,并在GRS课程期间与学员不断互动, 随后的GRC会议。 GRC将举办约28-30场特邀演讲,涵盖基础研究的主题, 临床应用与来自学术界和工业界的科学家非常动态的组合。据设想, 另外10-14个简短的演讲将主要由青年科学家从提交的摘要中选出。在 此外,研讨会亦会包括四个海报展览。 总的来说,2020年GRC将报告国际上最重要的最新研究进展。 抗体生物学和工程领域。本次会议提出的发现处于领先地位, 治疗性抗体的开发和临床应用。在创造性的悠久历史基础上, 在本系列的前三次会议中, 及其相关的GRS将为学术和生物制药研究人员提供理想的机会, 在世界各地建立网络并建立新的合作关系。我们设想,新的治疗应用是 可能会从这次会议上提出的想法的交叉授粉中产生。此外,通过 为年轻的研究人员提供机会,介绍他们的研究,并与更多的人讨论他们的工作。 作为一个成熟的科学家,这次会议将成为未来小组发展的重要跳板。 在这一迅速发展和至关重要的领域的研究人员。 1|页面
英文摘要
Project Description This application seeks partial support for the 2020 Gordon Research Conference (GRC) on Antibody Biology and Engineering, together with an accompanying Gordon Research Seminar (GRS) to be held on March 15- 20, 2020 at the Ventura Beach Marriott, CA, USA. This is the 6th GRC and the 4rthGRS on this topic which is representative of a highly exciting and influential meeting in the community. The aim of this meeting is to provide in-depth coverage of important recent developments in the rapidly evolving field of antibody biology and engineering, in an informal setting designed for maximal discussion and interaction. This field has broad implications for a wide variety of biologic and clinically significant topics that cut broadly across the multiple fields within the biomedical community, including immunity, infectious diseases, inflammation and oncology. Furthermore, for the fourth time in this meeting series, we will incorporate a Gordon Research Seminar (GRS). This has proved to be a highly successful addition to the Gordon Research Conference (GRC). The GRS will run immediately prior to the GRC. It will provide seminar and poster sessions specifically for graduate students, post-doctoral fellows, and early career scientists to allow them to present and discuss their research. As before, a GRS keynote speaker together with the GRC chairs, will offer support and advice through a mentorship session and continuous interactions with the trainees during the course of the GRS and subsequent GRC meeting. The GRC will host approximately 28-30 talks from invited speakers, spanning topics in basic research through clinical applications with a very dynamic mix of scientists from academia and industry. It is envisioned, that an additional 10-14 shorter talks will be given primarily by young scientists, selected from submitted abstracts. In addition, the GRC will also incorporate 4 poster sessions. Taken together, the 2020 GRC will report the most significant recent research advances in an international field of antibody biology and engineering. The discoveries presented this conference are at the leading edge in the therapeutic antibody development and clinical applications. Building on the long history of creative academia-industry interactions which have characterized the three previous meetings in this series, this GRC and its associated GRS will provide an ideal opportunity for academic and bio-pharma researchers from around the world to network and forge new collaborations. We envision that novel therapeutic applications are likely to ensue from the cross pollination of the ideas that will be presented at this meeting. Furthermore, by providing opportunities for younger researchers to present their studies and to discuss their work with more established scientists, this meeting will act as an important spring board for the development of a future group of investigators in this rapidly emerging and critically important field. 1|Page
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
海外基金